The global market for Urinary Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urinary Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Urinary Drugs by region & country, by Type, and by Application.

The Urinary Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Drugs.

Market Segmentation

Scope of Urinary Drugs - Market Report

Report Metric	Details
Report Name	Urinary Drugs - Market
CAGR	5%
Segment by Type:	Oral Injectables
Segment by Application	Hospital Clinic Home Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi S.A., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Pfizer Inc., Bayer AG, Allergan Plc., Otsuka Pharmaceutical Co., Ltd., GlaxosmithKline Plc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Urinary Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Urinary Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Urinary Drugs - Market report?

Ans: The main players in the Urinary Drugs - Market are Sanofi S.A., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Pfizer Inc., Bayer AG, Allergan Plc., Otsuka Pharmaceutical Co., Ltd., GlaxosmithKline Plc.

What are the Application segmentation covered in the Urinary Drugs - Market report?

Ans: The Applications covered in the Urinary Drugs - Market report are Hospital, Clinic, Home Care

What are the Type segmentation covered in the Urinary Drugs - Market report?

Ans: The Types covered in the Urinary Drugs - Market report are Oral, Injectables

1 Market Overview

1.1 Urinary Drugs Product Introduction

1.2 Global Urinary Drugs Market Size Forecast

1.2.1 Global Urinary Drugs Sales Value (2019-2030)

1.2.2 Global Urinary Drugs Sales Volume (2019-2030)

1.2.3 Global Urinary Drugs Sales Price (2019-2030)

1.3 Urinary Drugs Market Trends & Drivers

1.3.1 Urinary Drugs Industry Trends

1.3.2 Urinary Drugs Market Drivers & Opportunity

1.3.3 Urinary Drugs Market Challenges

1.3.4 Urinary Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Urinary Drugs Players Revenue Ranking (2023)

2.2 Global Urinary Drugs Revenue by Company (2019-2024)

2.3 Global Urinary Drugs Players Sales Volume Ranking (2023)

2.4 Global Urinary Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Urinary Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Urinary Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Urinary Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Urinary Drugs

2.9 Urinary Drugs Market Competitive Analysis

2.9.1 Urinary Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Urinary Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral

3.1.2 Injectables

3.2 Global Urinary Drugs Sales Value by Type

3.2.1 Global Urinary Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Urinary Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Urinary Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Urinary Drugs Sales Volume by Type

3.3.1 Global Urinary Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Urinary Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Urinary Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Urinary Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Home Care

4.2 Global Urinary Drugs Sales Value by Application

4.2.1 Global Urinary Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Urinary Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Urinary Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Urinary Drugs Sales Volume by Application

4.3.1 Global Urinary Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Urinary Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Urinary Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Urinary Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Urinary Drugs Sales Value by Region

5.1.1 Global Urinary Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Urinary Drugs Sales Value by Region (2019-2024)

5.1.3 Global Urinary Drugs Sales Value by Region (2025-2030)

5.1.4 Global Urinary Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Urinary Drugs Sales Volume by Region

5.2.1 Global Urinary Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Urinary Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Urinary Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Urinary Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Urinary Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Urinary Drugs Sales Value, 2019-2030

5.4.2 North America Urinary Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Urinary Drugs Sales Value, 2019-2030

5.5.2 Europe Urinary Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Urinary Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Urinary Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Urinary Drugs Sales Value, 2019-2030

5.7.2 South America Urinary Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Urinary Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Urinary Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Urinary Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Urinary Drugs Sales Value

6.2.1 Key Countries/Regions Urinary Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Urinary Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Urinary Drugs Sales Value, 2019-2030

6.3.2 United States Urinary Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Urinary Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Urinary Drugs Sales Value, 2019-2030

6.4.2 Europe Urinary Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Urinary Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Urinary Drugs Sales Value, 2019-2030

6.5.2 China Urinary Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Urinary Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Urinary Drugs Sales Value, 2019-2030

6.6.2 Japan Urinary Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Urinary Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Urinary Drugs Sales Value, 2019-2030

6.7.2 South Korea Urinary Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Urinary Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Urinary Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Urinary Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Urinary Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Urinary Drugs Sales Value, 2019-2030

6.9.2 India Urinary Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Urinary Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi S.A.

7.1.1 Sanofi S.A. Company Information

7.1.2 Sanofi S.A. Introduction and Business Overview

7.1.3 Sanofi S.A. Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi S.A. Urinary Drugs Product Offerings

7.1.5 Sanofi S.A. Recent Development

7.2 Astellas Pharma Inc.

7.2.1 Astellas Pharma Inc. Company Information

7.2.2 Astellas Pharma Inc. Introduction and Business Overview

7.2.3 Astellas Pharma Inc. Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Astellas Pharma Inc. Urinary Drugs Product Offerings

7.2.5 Astellas Pharma Inc. Recent Development

7.3 Daiichi Sankyo Company Limited

7.3.1 Daiichi Sankyo Company Limited Company Information

7.3.2 Daiichi Sankyo Company Limited Introduction and Business Overview

7.3.3 Daiichi Sankyo Company Limited Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Daiichi Sankyo Company Limited Urinary Drugs Product Offerings

7.3.5 Daiichi Sankyo Company Limited Recent Development

7.4 Pfizer Inc.

7.4.1 Pfizer Inc. Company Information

7.4.2 Pfizer Inc. Introduction and Business Overview

7.4.3 Pfizer Inc. Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Inc. Urinary Drugs Product Offerings

7.4.5 Pfizer Inc. Recent Development

7.5 Bayer AG

7.5.1 Bayer AG Company Information

7.5.2 Bayer AG Introduction and Business Overview

7.5.3 Bayer AG Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Bayer AG Urinary Drugs Product Offerings

7.5.5 Bayer AG Recent Development

7.6 Allergan Plc.

7.6.1 Allergan Plc. Company Information

7.6.2 Allergan Plc. Introduction and Business Overview

7.6.3 Allergan Plc. Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Allergan Plc. Urinary Drugs Product Offerings

7.6.5 Allergan Plc. Recent Development

7.7 Otsuka Pharmaceutical Co., Ltd.

7.7.1 Otsuka Pharmaceutical Co., Ltd. Company Information

7.7.2 Otsuka Pharmaceutical Co., Ltd. Introduction and Business Overview

7.7.3 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Offerings

7.7.5 Otsuka Pharmaceutical Co., Ltd. Recent Development

7.8 GlaxosmithKline Plc.

7.8.1 GlaxosmithKline Plc. Company Information

7.8.2 GlaxosmithKline Plc. Introduction and Business Overview

7.8.3 GlaxosmithKline Plc. Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 GlaxosmithKline Plc. Urinary Drugs Product Offerings

7.8.5 GlaxosmithKline Plc. Recent Development

8 Industry Chain Analysis

8.1 Urinary Drugs Industrial Chain

8.2 Urinary Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Urinary Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Urinary Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Otsuka Pharmaceutical Co Ltd

GlaxoSmithKline PLC

Company

Daiichi Sankyo Company Limited

List of Tables

Table 1. Urinary Drugs Market Trends

Table 2. Urinary Drugs Market Drivers & Opportunity

Table 3. Urinary Drugs Market Challenges

Table 4. Urinary Drugs Market Restraints

Table 5. Global Urinary Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Urinary Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Urinary Drugs Sales Volume by Company (2019-2024) & (K MT)

Table 8. Global Urinary Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Urinary Drugs Price by Company (2019-2024) & (USD/MT)

Table 10. Key Manufacturers Urinary Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Urinary Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Urinary Drugs

Table 13. Global Urinary Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Urinary Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Urinary Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Urinary Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Urinary Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Urinary Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Urinary Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)

Table 22. Global Urinary Drugs Sales Volume by Type (2019-2024) & (K MT)

Table 23. Global Urinary Drugs Sales Volume by Type (2025-2030) & (K MT)

Table 24. Global Urinary Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Urinary Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Urinary Drugs Price by Type (2019-2024) & (USD/MT)

Table 27. Global Urinary Drugs Price by Type (2025-2030) & (USD/MT)

Table 28. Global Urinary Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Urinary Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Urinary Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Urinary Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Urinary Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Urinary Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)

Table 34. Global Urinary Drugs Sales Volume by Application (2019-2024) & (K MT)

Table 35. Global Urinary Drugs Sales Volume by Application (2025-2030) & (K MT)

Table 36. Global Urinary Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Urinary Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Urinary Drugs Price by Application (2019-2024) & (USD/MT)

Table 39. Global Urinary Drugs Price by Application (2025-2030) & (USD/MT)

Table 40. Global Urinary Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Urinary Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Urinary Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Urinary Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Urinary Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Urinary Drugs Sales Volume by Region (K MT): 2019 VS 2023 VS 2030

Table 46. Global Urinary Drugs Sales Volume by Region (2019-2024) & (K MT)

Table 47. Global Urinary Drugs Sales Volume by Region (2025-2030) & (K MT)

Table 48. Global Urinary Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Urinary Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Urinary Drugs Average Price by Region (2019-2024) & (USD/MT)

Table 51. Global Urinary Drugs Average Price by Region (2025-2030) & (USD/MT)

Table 52. Key Countries/Regions Urinary Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Urinary Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Urinary Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Urinary Drugs Sales Volume, (2019-2024) & (K MT)

Table 56. Key Countries/Regions Urinary Drugs Sales Volume, (2025-2030) & (K MT)

Table 57. Sanofi S.A. Company Information

Table 58. Sanofi S.A. Introduction and Business Overview

Table 59. Sanofi S.A. Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 60. Sanofi S.A. Urinary Drugs Product Offerings

Table 61. Sanofi S.A. Recent Development

Table 62. Astellas Pharma Inc. Company Information

Table 63. Astellas Pharma Inc. Introduction and Business Overview

Table 64. Astellas Pharma Inc. Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 65. Astellas Pharma Inc. Urinary Drugs Product Offerings

Table 66. Astellas Pharma Inc. Recent Development

Table 67. Daiichi Sankyo Company Limited Company Information

Table 68. Daiichi Sankyo Company Limited Introduction and Business Overview

Table 69. Daiichi Sankyo Company Limited Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 70. Daiichi Sankyo Company Limited Urinary Drugs Product Offerings

Table 71. Daiichi Sankyo Company Limited Recent Development

Table 72. Pfizer Inc. Company Information

Table 73. Pfizer Inc. Introduction and Business Overview

Table 74. Pfizer Inc. Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 75. Pfizer Inc. Urinary Drugs Product Offerings

Table 76. Pfizer Inc. Recent Development

Table 77. Bayer AG Company Information

Table 78. Bayer AG Introduction and Business Overview

Table 79. Bayer AG Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 80. Bayer AG Urinary Drugs Product Offerings

Table 81. Bayer AG Recent Development

Table 82. Allergan Plc. Company Information

Table 83. Allergan Plc. Introduction and Business Overview

Table 84. Allergan Plc. Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 85. Allergan Plc. Urinary Drugs Product Offerings

Table 86. Allergan Plc. Recent Development

Table 87. Otsuka Pharmaceutical Co., Ltd. Company Information

Table 88. Otsuka Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 89. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 90. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Offerings

Table 91. Otsuka Pharmaceutical Co., Ltd. Recent Development

Table 92. GlaxosmithKline Plc. Company Information

Table 93. GlaxosmithKline Plc. Introduction and Business Overview

Table 94. GlaxosmithKline Plc. Urinary Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 95. GlaxosmithKline Plc. Urinary Drugs Product Offerings

Table 96. GlaxosmithKline Plc. Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Urinary Drugs Downstream Customers

Table 100. Urinary Drugs Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Urinary Drugs Product Picture

Figure 2. Global Urinary Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Urinary Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Urinary Drugs Sales Volume (2019-2030) & (K MT)

Figure 5. Global Urinary Drugs Sales Price (2019-2030) & (USD/MT)

Figure 6. Urinary Drugs Report Years Considered

Figure 7. Global Urinary Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Urinary Drugs Players Sales Volume Ranking (2023) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Urinary Drugs Revenue in 2023

Figure 10. Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Oral Picture

Figure 12. Injectables Picture

Figure 13. Global Urinary Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Urinary Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Urinary Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)

Figure 16. Global Urinary Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Urinary Drugs Price by Type (2019-2030) & (USD/MT)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Clinic

Figure 20. Product Picture of Home Care

Figure 21. Global Urinary Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Urinary Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Urinary Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)

Figure 24. Global Urinary Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Urinary Drugs Price by Application (2019-2030) & (USD/MT)

Figure 26. North America Urinary Drugs Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Urinary Drugs Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Urinary Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Urinary Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Urinary Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Urinary Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Urinary Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Urinary Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Urinary Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Urinary Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Urinary Drugs Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Urinary Drugs Sales Volume (%), (2019-2030)

Figure 38. United States Urinary Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Urinary Drugs Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Urinary Drugs Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Urinary Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Urinary Drugs Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Urinary Drugs Sales Value by Application (%), 2023 VS 2030

Figure 44. China Urinary Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Urinary Drugs Sales Value by Type (%), 2023 VS 2030

Figure 46. China Urinary Drugs Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Urinary Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Urinary Drugs Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Urinary Drugs Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Urinary Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Urinary Drugs Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Urinary Drugs Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Urinary Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Urinary Drugs Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Urinary Drugs Sales Value by Application (%), 2023 VS 2030

Figure 56. India Urinary Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Urinary Drugs Sales Value by Type (%), 2023 VS 2030

Figure 58. India Urinary Drugs Sales Value by Application (%), 2023 VS 2030

Figure 59. Urinary Drugs Industrial Chain

Figure 60. Urinary Drugs Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions